CRISPR-Cas9 Editing of Hematopoietic Stem and Progenitor Cells
In this webinar, Dr. Mark DeWitt, Postdoctoral Fellow at University of California, discuss the use of gene editing techniques for hematopoietic stem and progenitor cells (HSPCs).
Publish Date:
June 26, 2018
Request Pricing
Thank you for your interest in this product. Please provide us with your contact information and your local representative will contact you with a customized quote. Where appropriate, they can also assist you with a(n):
Estimated delivery time for your area
Product sample or exclusive offer
In-lab demonstration
By submitting this form, you are providing your consent to STEMCELL Technologies Canada Inc. and its subsidiaries and affiliates (“STEMCELL”) to collect and use your information, and send you newsletters and emails in accordance with our privacy policy. Please contact us with any questions that you may have. You can unsubscribe or change your email preferences at any time.
Related Multimedia
-
Targeting Self-Renewal Function in Normal Hematopoietic and Leukemic Stem Cells
Publish Date: February 03, 2017 -
Using CRISPR/Cas9 to Model Stem Cell Organization and Dynamics
Publish Date: August 25, 2017 -
New Tools for the Ex Vivo Expansion of Human Hematopoietic Stem and Progenitor Cells
Publish Date: March 09, 2015
Explore Our Products
-
Methylcellulose-based medium with recombinant cytokines for human cells -
Serum-free culture supplement for expansion of human hematopoietic cells -
ArciTect™ Human HPRT Positive Control Kit
Positive control for CRISPR-Cas9 genome editing -
Serum-free medium for culture and expansion of hematopoietic cells
